Ultralife Corporation
ULBI
$5.48
$0.142.62%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 35.69M | 42.98M | 41.93M | 44.55M | 39.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.69M | 42.98M | 41.93M | 44.55M | 39.49M |
| Cost of Revenue | 27.01M | 31.42M | 30.46M | 33.15M | 29.71M |
| Gross Profit | 8.68M | 11.56M | 11.47M | 11.40M | 9.77M |
| SG&A Expenses | 5.82M | 5.65M | 5.65M | 5.90M | 5.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.93M | 39.07M | 37.86M | 40.90M | 37.35M |
| Operating Income | 761.00K | 3.92M | 4.06M | 3.65M | 2.14M |
| Income Before Tax | 353.00K | 3.85M | 3.61M | 3.11M | 1.75M |
| Income Tax Expenses | 74.00K | 853.00K | 703.00K | 263.00K | 446.00K |
| Earnings from Continuing Operations | 279.00K | 2.99M | 2.90M | 2.85M | 1.30M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -21.00K | -24.00K | -13.00K | 23.00K | 27.00K |
| Net Income | 258.00K | 2.97M | 2.89M | 2.87M | 1.33M |
| EBIT | 761.00K | 3.92M | 4.06M | 3.65M | 2.14M |
| EBITDA | 1.76M | 4.93M | 5.03M | 4.62M | 3.12M |
| EPS Basic | 0.02 | 0.18 | 0.18 | 0.18 | 0.08 |
| Normalized Basic EPS | 0.02 | 0.14 | 0.14 | 0.06 | 0.07 |
| EPS Diluted | 0.02 | 0.18 | 0.18 | 0.17 | 0.08 |
| Normalized Diluted EPS | 0.02 | 0.14 | 0.14 | 0.06 | 0.07 |
| Average Basic Shares Outstanding | 16.63M | 16.57M | 16.40M | 16.34M | 16.24M |
| Average Diluted Shares Outstanding | 16.87M | 16.83M | 16.52M | 16.48M | 16.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
